Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Serum NGAL is Associated with Distinct Plasma Amyloid-β Peptides According to the Clinical Diagnosis of Dementia in Down Syndrome
Home
Publications
Serum NGAL is Associated with Distinct Plasma Amyloid-β Peptides According to the Clinical Diagnosis of Dementia in Down Syndrome
Serum NGAL is Associated with Distinct Plasma Amyloid-β Peptides According to the Clinical Diagnosis of Dementia in Down Syndrome
Authors:
PN
Petrus J.W. Naudé
Petrus J.W. Naudé
AD
Alain D. Dekker
Alain D. Dekker
AC
Antonia M.W. Coppus
Antonia M.W. Coppus
YV
Yannick Vermeiren
Yannick Vermeiren
UE
Ulrich L.M. Eisel
Ulrich L.M. Eisel
CD
Cornelia M. van Duijn
Cornelia M. van Duijn
DD
Debby Van Dam
Debby Van Dam
PD
Peter P. De Deyn
Peter P. De Deyn
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Download PDF
Download
Publisher website
Google Scholar
24 March 2015
journal article
Published by
SAGE Publications
in
Journal of Alzheimer’s Disease
Vol. 45
(3)
,
733-743
DOI:
10.3233/jad-142514
PMID:
25613101
Abstract
Background: The majority of people with Down syndrome (DS) develop dementia due to Alzheimer’s disease (AD). Neuropathological features are characterized by an accumulation of amyloid-β (Aβ) deposits and the presence of an activated immune response.
Keywords
ALZHEIMER'S DISEASE
AMYLOID-Β
APOLIPOPROTEIN E
BIOMARKER
DOWN SYNDROME
INFLAMMATION
LIPOCALIN 2
PLATELETS
Related articles
Cited
Cited by 19 articles
Scroll to top